Roberta Rudà

14.8k total citations · 4 hit papers
217 papers, 6.3k citations indexed

About

Roberta Rudà is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Roberta Rudà has authored 217 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Genetics, 108 papers in Pulmonary and Respiratory Medicine and 51 papers in Epidemiology. Recurrent topics in Roberta Rudà's work include Glioma Diagnosis and Treatment (171 papers), Brain Metastases and Treatment (103 papers) and Meningioma and schwannoma management (47 papers). Roberta Rudà is often cited by papers focused on Glioma Diagnosis and Treatment (171 papers), Brain Metastases and Treatment (103 papers) and Meningioma and schwannoma management (47 papers). Roberta Rudà collaborates with scholars based in Italy, United States and Switzerland. Roberta Rudà's co-authors include Riccardo Soffietti, Elisa Trevisan, Alessia Pellerino, Michael Weller, Émilie Le Rhun, Roberto Mutani, Martin J. van den Bent, Matthias Preusser, Dieta Brandsma and Lorenzo Bello and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Roberta Rudà

197 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

2017 426 citations Émilie Le Rhun, Michael Weller et al. profile →
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)

2016 339 citations Riccardo Soffietti, Brigitta G. Baumert et al. Neuro-Oncology profile →
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

2018 257 citations Giuseppe Lombardi, Gian Luca De Salvo et al. profile →
Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance

2021 157 citations Francesca Mo, Alessia Pellerino et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberta Rudà Italy	41	4.1k	3.1k	1.8k	1.1k	1.1k	217	6.3k
Émilie Le Rhun France	45	3.6k 0.9×	4.5k 1.4×	3.4k 1.9×	1.3k 1.1×	819 0.7×	237	7.8k
Steven N. Kalkanis United States	39	2.6k 0.6×	2.3k 0.7×	1.4k 0.8×	1.3k 1.1×	675 0.6×	132	5.5k
Georg Widhalm Austria	40	2.7k 0.7×	2.0k 0.6×	1.6k 0.9×	879 0.8×	669 0.6×	213	5.7k
Lakshmi Nayak United States	33	2.9k 0.7×	2.1k 0.7×	1.8k 1.0×	915 0.8×	1.3k 1.2×	128	5.5k
Philippe Métellus France	38	2.2k 0.5×	1.8k 0.6×	993 0.6×	1.2k 1.1×	1.3k 1.2×	170	5.3k
Xiaobu Ye United States	39	2.3k 0.6×	1.4k 0.5×	2.6k 1.5×	946 0.8×	644 0.6×	151	6.8k
Rolf‐Dieter Kortmann Germany	45	5.0k 1.2×	3.6k 1.2×	2.1k 1.2×	1.9k 1.7×	1.8k 1.6×	227	8.2k
Jan Drappatz United States	42	3.0k 0.7×	1.2k 0.4×	1.1k 0.6×	934 0.8×	1.1k 1.0×	155	5.3k
Do‐Hyun Nam South Korea	44	2.1k 0.5×	1.6k 0.5×	1.3k 0.7×	1.4k 1.3×	889 0.8×	239	6.7k
Michael Brada United Kingdom	43	3.3k 0.8×	2.9k 0.9×	840 0.5×	1.2k 1.1×	1.1k 1.0×	91	6.7k

Countries citing papers authored by Roberta Rudà

Since Specialization

Citations

This map shows the geographic impact of Roberta Rudà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Rudà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Rudà more than expected).

Fields of papers citing papers by Roberta Rudà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Rudà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Rudà. The network helps show where Roberta Rudà may publish in the future.

Co-authorship network of co-authors of Roberta Rudà

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Rudà. A scholar is included among the top collaborators of Roberta Rudà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Rudà. Roberta Rudà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rudà, Roberta, et al.. (2025). Early seizure freedom with [ ¹⁸ F ]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report. Epilepsia. 66(10). e242–e247.

Michelucci, Roberto, Giada Pauletto, Antonio Silvani, et al.. (2025). Tumor‐related epilepsy in glioma: A multidisciplinary overview. Epilepsia. 66(10). 3621–3641.

Bonaventura, Rina Di, Silvia Chiesa, Alessia Pellerino, et al.. (2025). Education paths in neuro-oncology: combining technical skills with multidisciplinary care. A survey from the AINO (Italian Association for Neuro-Oncology) Youngster Committee. Journal of Neuro-Oncology. 173(2). 469–477.

Baumert, Brigitta G., Vera C. Keil, Norbert Galldiks, et al.. (2024). ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma. Radiotherapy and Oncology. 202. 110594–110594. 1 indexed citations

Galldiks, Norbert, Timothy J. Kaufmann, Philipp Kickingereder, et al.. (2024). Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group. Neuro-Oncology. 26(7). 1181–1194. 21 indexed citations

Rudà, Roberta, et al.. (2024). Financial challenges of being on long-term, high-cost medications. Neuro-Oncology Practice. 12(Supplement_1). i49–i58. 4 indexed citations

Bruno, Francesco, Alessia Pellerino, Marco Conti Nibali, et al.. (2024). Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With IDH1/2 -Mutant Lower-Grade Glioma. Neurology. 102(10). e209352–e209352. 6 indexed citations

Rhun, Émilie Le, Mary Jane Lim-Fat, Roberta Rudà, et al.. (2024). NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases. Neuro-Oncology. 27(2). 455–465. 1 indexed citations

Nayak, Lakshmi, Chetan Bettegowda, Florian Scherer, et al.. (2024). Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review. Neuro-Oncology. 26(6). 993–1011. 11 indexed citations

10.

Bruno, Francesco, et al.. (2023). Newly diagnosed glioblastoma: A review on clinical management. Elsevier eBooks. 101–123.

11.

Pellerino, Alessia, Francesco Bruno, Riccardo Soffietti, & Roberta Rudà. (2023). Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?. Current Oncology Reports. 25(7). 777–785. 14 indexed citations

12.

Furtner, Julia, Johan Pallud, Franck Bielle, et al.. (2023). Rare Neuronal, Glial and Glioneuronal Tumours in Adults. Cancers. 15(4). 1120–1120. 5 indexed citations

13.

Soffietti, Riccardo, Chetan Bettegowda, Ingo K. Mellinghoff, et al.. (2022). Liquid biopsy in gliomas: A RANO review and proposals for clinical applications. Neuro-Oncology. 24(6). 855–871. 63 indexed citations

14.

Indraccolo, Stefano, Gian Luca De Salvo, Mario Caccese, et al.. (2020). Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker Analysis. Clinical Cancer Research. 26(17). 4478–4484. 28 indexed citations

15.

Rossi, Marco, Lorenzo Gay, Federico Ambrogi, et al.. (2020). Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas. Neuro-Oncology. 23(5). 812–826. 79 indexed citations

16.

Rhun, Émilie Le, Patrick Devos, Johannes Weller, et al.. (2020). Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro-Oncology. 23(7). 1100–1112. 69 indexed citations

17.

Zaccara, Gaetano, Vincenzo Esposito, Marta Maschio, et al.. (2020). A survey on clinical pathways of patients with epilepsy and cerebrovascular diseases or brain tumors. Neurological Sciences. 41(6). 1507–1511. 1 indexed citations

18.

Gambella, Alessandro, Rebecca Senetta, Stefano Vallero, et al.. (2020). NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target. International Journal of Molecular Sciences. 21(3). 753–753. 71 indexed citations

19.

Costanza, Alessandra, Francesco Zenga, Roberta Rudà, et al.. (2020). Suicidality in Patients with Brain Tumors: A Brief Literature Review with Clinical Exemplar. Medicina. 56(12). 725–725. 5 indexed citations

20.

Boire, Adrienne, Dieta Brandsma, Priscilla K. Brastianos, et al.. (2019). Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. Neuro-Oncology. 21(5). 571–584. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact